Actively Recruiting
Interest of the Immunoscore® as a Post-operative Complementary Tool for the Detection of the Risk of Recurrence in Patients With Nonmetastatic Colorectal Cancer
Led by Hospital St. Joseph, Marseille, France · Updated on 2022-04-13
100
Participants Needed
2
Research Sites
312 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Evaluate the patient care recommandation induced by the IMMUNOSCORE® result
CONDITIONS
Official Title
Interest of the Immunoscore® as a Post-operative Complementary Tool for the Detection of the Risk of Recurrence in Patients With Nonmetastatic Colorectal Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 80 years inclusive
- Histologically confirmed colon adenocarcinoma
- Curative resection of stage I, II, or III colorectal cancer
- Diagnosed T1, T2, T3, or T4 and N0, N1, or N2
- Eligible to receive 6 months of adjuvant chemotherapy
- Provided free, informed, and written consent
- Agree to use of tumor sample for research
- Affiliated with a social security system
You will not qualify if you...
- Pregnant or breastfeeding women
- Legal incapacity or conditions preventing consent or study completion
- History of other solid tumors within 3 years except controlled in-situ cervical or skin cancers
- Person subject to a safeguard measure
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Hôpital Européen
Marseille, France, 13003
Not Yet Recruiting
2
Hopital Saint Joseph
Marseille, France, 13008
Actively Recruiting
Research Team
C
Cécile BIELMANN
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here